Ultrastructural and biochemical analyses reveal that the detailed composition and structure of tau deposits differ between CBD and PSP, despite both of these diseases being 4R tauopathies (Arai et al., 2004; Taniguchi-Watanabe et al., 2016). The gene discussed is MAPT; the disease is tauopathy.